The ASX healthcare sector rose this week, with Morgans' Scott Power noting momentum is returning to the sector. ... Read More ...
“Blessed are the peacemakers,” Trump wrote on social media. Well, they sure are, Mr. President, and now that you have brought ...
Amyotrophic lateral sclerosis may involve an autoimmune component — a finding that could reshape treatment strategies and ...
Researchers identified immune cells that attacked the neuronal protein C9orf72 in individuals with ALS, spurring new ...
Neurizon is gearing up to begin its HEALEY ALS platform trial later this year after the FDA lifted a clinical hold on its ...
Northwestern University professor Hande Ozdinler is hoping to change how ALS is treated, saying the disease is too complex ...
Neurosense Therapeutics Ltd. ( ($NRSN) ) has issued an update. On October 6, 2025, NeuroSense Therapeutics Ltd. announced that its drug candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback